Non-Hodgkin's lymphoma (NHL) is cancer of the lymphatic system, a vital part of the body's immune system. Symptoms include swollen lymph nodes, fever, night sweats, coughing, weakness, chest pain, unexplained weight loss, and abdominal pain. Learn about
There are various methods to treat of Non-Hodgkin lymphoma. Once the condition has been diagnosed then the team of doctors decides the way of treatment based on the stage and location of cancer. If the Non-Hodgkin lymphoma is detected on early stage then, it is easy to treat the condition...
High Survival Rate in Childhood Non-Hodgkin Lymphoma without CNS Involvement: Results of BFM 95 Study in Kuwaitdoi:10.1080/0880010390158603Non-Hodgkin lymphomas (NHL) in children are the second most common malignant tumors in Kuwait. Until 1995 the patients (pts) received institutional protocols. ...
We also measured the serum IL-18 levels in patients with various hematologic disorders [5]. In the present study we investigated 27 patients with non-Hodgkin's lymphoma. 展开 关键词: Interleukin-18 Lymphoma, Non Hodgkin blood 白细胞介素18 ...
B cell acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) frequently express CD19, CD20 and CD22 on the cell surfaces. Immunotherapeutic agents including antibodies and chimeric antigen receptor T cells are widely studied in clinical trial
Biomarker Research (2019) 7:9 https://doi.org/10.1186/s40364-019-0160-4 REVIEW Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma Amandeep Aujla1, Ravijot Aujla2 and Delong Liu1,3* Open Access Abstract B cell acute lymphoblastic leukemia (ALL...
ClinicoEconomics and Outcomes Research Dovepress open access to scientific and medical research Open Access Full Text Article re v i e w Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness Firas Badin John Hayslip University of Kentucky, ...
KEYTRUDA is indicated for the treatment of adult patients with relapsed or refractory classical Hodgkin lymphoma (cHL). KEYTRUDA is indicated for the treatment of pediatric patients with refractory cHL, or cHL that ...
Classical Hodgkin Lymphoma KEYTRUDA is indicated for the treatment of adult patients with relapsed or refractory classical Hodgkin lymphoma (cHL). KEYTRUDA is indicated for the treatment of pediatric patients with refracto...
There is no universal recommendation for managing the reactivation of HBV in patients with resolved HBV infection treated with anti-CD20 monoclonal antibodies for B-cell non-Hodgkin lymphoma. This study compared the cost-effectiveness of two commonly used strategies: prophylactic anti-HBV nucleos(t)id...